US Markets are Currently Closed - 11/22/2009 at 3:40:24 AM EST Market Indexes: SPY $109.43 (0.36%) DIA $103.25 (0.06%) QQQQ $43.44 (0.50%) Biggest Gains: PALG $22.92 (14.60%) PCS $6.52 (6.54%) NMR $6.84 (6.21%) DBRN $21.68 (5.65%) SVR $16.75 (5.61%) Biggest Losses: DHI $10.37 (15.35%) DELL $14.29 (9.96%) NUVA $33.80 (9.02%) SBAY $14.00 (8.08%) CEA $35.76 (5.80%) Recently Viewed Stocks: ADGF $2.96 (1.33%) CHK $23.03 (1.50%) HEPH $0.49 (6.65%) IBM $126.96 (0.45%) MSFT $29.62 (0.54%) TKLC $14.38 (2.24%)

HOLLIS-EDEN PHARMACEUT (NASDAQ: HEPH)

0.03 (6.65%)

$0.49

Real-time: $0.49 -0.03 (-6.65%) 12:00:00 AM ET

Quote Charts Option Chain News Historical Executives Earnings Ratios Statement Balance Sheet Cash Flow

You need to upgrade your Flash Player to view the graph.

View Advanced Charts

View by Date Range:

Are you Bullish or Bearish on HEPH?

Investors are 0% Bullish and 100% Bearish on HEPH

Key Stats

Market Cap

0.02 B

Diluted EPS (TTM)

-0.74

P/E Ratio (TTM)

0.0

52-Week High Price

0.98

52-Week Low Price

0.27

Avg Volume (3 Mo.)

0.00 M

Beta

0.18

29.42 M

Dividend Rate ($)

0.00

Dividend Rate (%)

0.00

12 Mo. Price Change : N/A

Click Here For Free HEPH Annual Reports

Similar Companies

Name	Most Recent Price	Today's Change	Market Cap
XENOMICS INC (XNOM)	$0.68	$0.05(6.85%)	0.02 B
NEUROLOGIX INC (NRGX)	$0.55	$0.00(0.00%)	0.02 B
OHR PHARMACEUTICAL INC (OHRP)	$0.60	$0.00(0.00%)	0.02 B
OSTEOLOGIX INC (OLGX)	$0.50	$0.01(1.96%)	0.02 B
PULMO BIOTECH INC (PLMO)	$0.27	$0.01(3.57%)	0.02 B
ADVENTRX PHARMACEUTICALS (ANX)	$0.10	$0.00(0.00%)	0.02 B
ANGEION CORP (ANGN)	$3.60	$0.05(1.32%)	0.02 B
CHEM RX CORPORATION CO... (CHRX)	$0.37	$0.00(0.00%)	0.01 B
CYANOTECH CORP (CYAN)	$2.83	$0.07(2.53%)	0.01 B
LIFEVANTAGE CORP (LFVN)	$0.23	$0.01(4.17%)	0.01 B

HEPH Headlines
More Stock Ideas

BRIEF-Hollis Eden Pharmaceuticals reducing workforce by about 33 pct
Forbes.com 2/2/2009

Midweek Stocks
<ul> <li>Pneumonia drug pending FDA approval</li> <li>Hollis-Eden's developing treatments for cancer and diabetes</li> <li>A ground breaking product for thyroid cancer</li> <li>AspenBio's new blood test</li> </ul>
Wall Street Media 11/19/2008

Richard Hollis, Chairman, President and CEO of Hollis-Eden Pharmaceuticals Talks to The Wall Street Transcript
Richard Hollis, Chairman, President and CEO of Hollis-Eden Pharmaceuticals Talks to The Wall Street Transcript
At BusinessWire 11/17/2008

Biotech Stock News
<ul> <li>Rodman & Renshaw Annual Global Investment Conference</li> <li>CombinatoRx introduces Synavive</li> <li>Mannkind announces AFRESA for new insulin trials</li> <li>Hollis-Eden announces Triolex in Phase II</li> <ul>
Wall Street Media 11/10/2008

Hollis-Eden Pharmaceuticals Updates Upcoming Investor Conference Presentations and Webcasts
Hollis-Eden Pharmaceuticals Updates Upcoming Investor Conference Presentations and Webcasts
At BusinessWire 11/7/2008

Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Programs; Announces Third Quarter 2008 Financial Results
Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Programs; Announces Third Quarter 2008 Financial Results
At BusinessWire 11/6/2008

View All Headlines